Advertisement
Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in S. Africa, Europe, or N. America

September 9, 2014

Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in S. Africa, Europe, or N. America

Analyzing survival in HIV treatment cohorts, Andrew Boulle and colleagues find mortality rates in South Africa comparable to or better than those in North America by 4 years after starting antiretroviral therapy.

Image credit: Rico Gustav, Flickr

PLOS Medicine announces its 10th anniversary this October!

Celebrating 10 years of publishing outstanding research and commentary on the major challenges to human health worldwide.